Anti PD-1/PD-L1 therapy uses PD-1/PD-L1 immune checkpoint inhibitor antibodies to interfere with PD-1/PD-L1 mediated signal transduction to restore anti-tumor immunity. The gene discussed is PDCD1; the disease is neoplasm.